Abstract
Introduction
Synovial sarcomas are mesenchymal malignancies that most often affect the lower extremities of young adults. These tumors are classified into monophasic and biphasic variants. IHC plays a major role in diagnosis (1) . About 3-9% of cases were reported in the head and neck region while laryngeal involvement is rare, which makes the correct diagnosis difficult for the pathologist and the clinician (2, 3) . The Treatment of synovial sarcoma is surgery, radiation therapy, and chemotherapy (4) . About 18 cases of synovial sarcoma of the larynx were reported in the Englishlanguage literature (5) . In this case report, a 23-year-old man, who presented with odynophagia, dysphagia, and voice change, is reported. To the best of our knowledge, this is another case of synovial sarcoma of the larynx.
Case Report
A 23-year-old male was admitted to the ENT department of the University Hospital because of increasing hoarseness for eight months, and dysphagia, odynophagia, and dyspnea since nearly one year ago. He had no weight loss, otalgia, hemoptysis, or constitutional signs of any diseases. Upon indirect laryngoscopic examination, an endolaryngeal submucosal mass, involving the epiglottis and aryepiglottis fold, was discovered. True vocal cords were normal. No masses were palpable in his neck. The results of laboratory studies were normal. A computed tomography (CT) scan was valuable in determining the site of origin and extent of the lesion, that revealed a solid mass, which extended from the hypopharynx into the epiglottis and the area of the aryepiglottis fold, particularly in the left side ( Fig.1 ). Using the microlaryngoscopic procedure, a biopsy sampling was taken from the laryngeal mass. Following that, a wide surgical excision of the tumor with a free margin was performed. Radiotherapy was added. (Fig.2) . 
Treatment
A wide surgical excision of the tumor was planned. The tumor extended from the hypopharynx into the epiglottis and the area of the aryepiglottis fold in the left side and was excised with free margins. Elective radical neck dissection was not performed; but the patient received radiotherapy after surgery with no recurrence after 42 months.
Discussion
Synovial sarcoma of the larynx was first described early in the 20th century. The least frequent site of occurrence is the larynx. Until 1975, only four cases have been reported (6) . Since then, only 19 cases have been reported, including the current case (Table. 1) (6). The reported cases included 14 males, 3 females, and one case in which the patient's sex was not reported (5) . Hoarseness, upper respiratory distress, and dysphagia characterize the original complaints in laryngopharyngeal synovial sarcoma (6) . Our case presented with increasing hoarseness for eight months, and dysphagia, odynophagia, and dyspnea since nearly one year ago. He had no weight loss, otalgia, and hemoptysis. In our case, true vocal cords were normal and the mass was found submucosally in the supraglotic region and hypopharynx.
Primary tumors of the larynx are predominantly classified as squamous cell carcinoma. Other unusual tumors in this location are fibrosarcoma, chondrosarcoma, osteosarcoma, and rhabdomyosarcoma (7, 8) .
Biphasic synovial sarcoma causes very few problems in its diagnosis; however, synovial sarcoma can display different patterns. The monophasic fibrous type can be misdiagnosed as a spindle cell sarcoma or a hemangiopericytoma (9) . Diagnosis of our cases after IHC stains showed well differentiated synovial sarcoma of the biphasic type. The optimal treatment strategy for synovial sarcoma has not yet been established. Although surgical excision with a wide margin is currently performed as the first treatment of choice, the efficacy of other treatments such as chemotherapy or radiotherapy has not yet been debated (10) . Lymph node metastasis is rare and hematogenous spread is more probable, with the lung being the most common site of metastasis. Routine radical neck dissection is not recommended. In this case report, we present a case of synovial sarcoma of the larynx, which was treated with a wide surgical excision with a safe margin, after which the patient received radiotherapy with no recurrence after 42 months.
Conclusion
With this case report, another new case of synovial sarcoma of the endolarynx is added to literature. Due to the presence of very few cases of laryngeal synovial sarcomas, every new case will bring some new information about diagnosis and therapy. Every case of synovial sarcoma should be published because it is of utmost importance to get to know new aspects and therapeutical modalities of this rare tumor.
